This course will cover changes in the prevalence of cancer and contemporary diagnostics and treatments. While these have dramatically decreased mortality, cancer continues to claim more than 585,000 lives annually. Therefore, the focus will be on the mechanisms that are corrupted in cancer cells and the differences in vulnerability among tissues, the technologies used to define pathways and lessons learned. Equally important are the strategies being used to exploit the vulnerabilities of tumors for personalized and targeted therapeutics.
Leonid A. Pobezinsky
ANIMLSCI 200 or BIOCHEM 275, BIOLOGY 285 and ANIMLSCI 311 or BIOLOGY 283 both with a grade of C or better. or Graduate Student status